BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19286909)

  • 1. Treatment of systemic juvenile idiopathic arthritis.
    Hinze CH; Foell D; Kessel C
    Nat Rev Rheumatol; 2023 Dec; 19(12):778-789. PubMed ID: 37923864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.
    Ambler WG; Nanda K; Onel KB; Shenoi S
    Ann Med; 2022 Dec; 54(1):1839-1850. PubMed ID: 35786149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?
    Moura RA; Fonseca JE
    Front Med (Lausanne); 2022; 9():851532. PubMed ID: 35449805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.
    Kaegi C; Wuest B; Schreiner J; Steiner UC; Vultaggio A; Matucci A; Crowley C; Boyman O
    Front Immunol; 2019; 10():1990. PubMed ID: 31555262
    [No Abstract]   [Full Text] [Related]  

  • 5. Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
    Kearsley-Fleet L; Sampath S; McCann LJ; Baildam E; Beresford MW; Davies R; De Cock D; Foster HE; Southwood TR; Thomson W; Hyrich KL
    Rheumatology (Oxford); 2019 Feb; 58(2):331-335. PubMed ID: 30358861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options.
    Pagnini I; Bertini F; Cimaz R
    Paediatr Drugs; 2016 Apr; 18(2):101-8. PubMed ID: 26939782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of polyarticular juvenile idiopathic arthritis.
    Webb K; Wedderburn LR
    Curr Opin Rheumatol; 2015 Sep; 27(5):505-10. PubMed ID: 26147756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of juvenile idiopathic arthritis: a revolution in care.
    Stoll ML; Cron RQ
    Pediatr Rheumatol Online J; 2014; 12():13. PubMed ID: 24782683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B-cell targeted therapy for children and adolescents with rheumatic diseases].
    Morbach H; Girschick HJ
    Z Rheumatol; 2013 May; 72(4):347-53. PubMed ID: 23609932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of biologics in the treatment of juvenile idiopathic arthritis: a factor not to be overlooked.
    Prince FH; van Suijlekom-Smit LW
    Paediatr Drugs; 2013 Aug; 15(4):271-80. PubMed ID: 23606042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic arthritis in children: a review of clinical presentation and treatment.
    Gurion R; Lehman TJ; Moorthy LN
    Int J Inflam; 2012; 2012():271569. PubMed ID: 22235382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis.
    Alexeeva EI; Valieva SI; Bzarova TM; Semikina EL; Isaeva KB; Lisitsyn AO; Denisova RV; Chistyakova EG
    Clin Rheumatol; 2011 Sep; 30(9):1163-72. PubMed ID: 21384257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.
    Buch MH; Smolen JS; Betteridge N; Breedveld FC; Burmester G; Dörner T; Ferraccioli G; Gottenberg JE; Isaacs J; Kvien TK; Mariette X; Martin-Mola E; Pavelka K; Tak PP; van der Heijde D; van Vollenhoven RF; Emery P;
    Ann Rheum Dis; 2011 Jun; 70(6):909-20. PubMed ID: 21378402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety profile of biologic therapies for juvenile idiopathic arthritis.
    Hashkes PJ; Uziel Y; Laxer RM
    Nat Rev Rheumatol; 2010 Oct; 6(10):561-71. PubMed ID: 20808294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of biologicals in the treatment of SoJIA].
    Dückers G; Niehues T
    Z Rheumatol; 2010 Aug; 69(6):505-15. PubMed ID: 20668866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab.
    Kuek A; Hazleman BL; Gaston JH; Ostör AJ
    Rheumatology (Oxford); 2006 Nov; 45(11):1448-9. PubMed ID: 16920752
    [No Abstract]   [Full Text] [Related]  

  • 18. [Juvenile rheumatoid arthritis].
    Honkanen V; Lahdenne P
    Duodecim; 2000; 116(8):839-43. PubMed ID: 11787127
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of juvenile idiopathic arthritis].
    Yokota S; Umebayashi H; Katakura S; Imagawa T; Mori M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():453-8. PubMed ID: 15799398
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.